Bullish Moving Averages
13
Bearish Moving Averages
3
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
815.50Today’s High
833.0052W low
657.0052W High
903.80Open Price
833.00Prev. Close
680.7000Volume
103368.00Value
84741086.40Fundamentals
Market Cap
4529.20
Price to Earnings
34.70
Price to Book Value
4.30
Dividend Yield
0.00
PE to Growth
1.60
Op Revenue TTM
1830.56
Net Profit TTM
130.69
Cash From Operating Activity
43.26
Return on Equity %
12.47
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
46.7
Week
46
Month
48.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
822.77
PIVOT
First Resistance
830.03
Second Resistance
840.27
Third Resistance
847.53
First Support
812.53
Second Support
805.27
Third Support
795.03
Relative Strength Index
64.64
Money Flow Index
70.47
MACD
30.87
MACD Signal
29.39
Average True Range
25.85
Average Directional Index
32.18
Rate of Change (21)
20.52
Rate of Change (125)
3.8
Commodity Channel Index
53.1
Williams %R
-43.7
BETA
1 Month
-0.03
3 Month
0.32
1 Year
0.46
3 Year
0.35
PRICE CHANGE ANALYSIS
↑ 0.51%
1 Week
Low
High
806.55
868.9
↑ 22.24%
1 Month
Low
High
658.2
868.9
↑ 13.11%
3 Months
Low
High
658.2
868.9
↓ -0.08%
6 Months
Low
High
656.95
868.9
↓ -3.47%
1 Year
Low
High
656.95
903.85
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 315.15 | 300.88 | 333.98 | 259.68 | 265.96 | 237.15 | 241.30 | 234.37 | 263.58 | 274.24 | 341.89 | |
| Operating Expenses Qtr | 272.08 | 257.61 | 289.67 | 223.21 | 227.85 | 204.98 | 213.02 | 206.68 | 234.18 | 242.55 | 301.14 | |
| Operating Profit Qtr | 41.72 | 41.14 | 42.34 | 35.14 | 35.79 | 31.92 | 27.88 | 27.06 | 27.47 | 26.10 | 37.48 | |
| EBIDT Qtr Cr | 43.06 | 43.27 | 44.30 | 36.47 | 38.11 | 32.17 | 28.28 | 27.69 | 29.40 | 31.70 | 40.75 | |
| Depreciation Qtr | 6.58 | 5.84 | 6.26 | 5.51 | 6.72 | 6.68 | 6.38 | 6.21 | 7.08 | 6.76 | 6.40 | |
| Net Profit Qtr | 26.17 | 25.54 | 26.38 | 21.56 | 23.14 | 17.46 | 15.42 | 15.37 | 16.87 | 18.27 | 24.41 | |
| Basic EPS Qtr | 4.74 | 4.62 | 4.78 | 3.91 | 4.20 | 3.17 | 2.80 | 2.79 | 3.06 | 3.32 | 4.44 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1209.68 | 978.77 | 1085.54 | 700.62 | 603.73 | |
| Operating Expenses Annual Cr | 1041.66 | 852.52 | 950.05 | 569.56 | 495.09 | |
| Operating Profit Annual | 161.25 | 122.65 | 122.79 | 120.86 | 105.01 | |
| Operating Profit Margin Annual % | 13.33 | 12.53 | 11.31 | 17.25 | 17.39 | |
| Total Expenses Annual Cr | 1075.55 | 883.12 | 978.86 | 594.62 | 515.62 | |
| EBIDT Annual Cr | 168.03 | 126.25 | 135.49 | 131.06 | 108.64 | |
| EBIDT Annual margin % | 13.89 | 12.90 | 12.48 | 18.71 | 17.99 | |
| Depreciation | 24.19 | 25.98 | 26.27 | 22.07 | 16.85 | |
| PAT Before ExtraOrdinary Items Annual Cr | 99.64 | 71.39 | 79.47 | 79.10 | 65.52 | |
| Net Profit Annual | 99.64 | 71.39 | 79.47 | 79.10 | 65.52 | |
| Basic EPS Annual | 18.05 | 12.95 | 14.49 | 15.34 | 13.48 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 960.34 | 858.70 | 784.52 | 404.44 | 283.47 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 37.69 | 37.06 | 1.23 | 0.99 | 36.13 | |
| Total Current Liabilities Annual Cr | 283.14 | 229.91 | 140.18 | 138.93 | 148.69 | |
| Total Capital Plus Liabilities Annual Cr | 1281.17 | 1125.67 | 925.93 | 544.36 | 468.29 | |
| Fixed Assets Annual | 191.89 | 169.11 | 178.22 | 171.07 | 115.29 | |
| Total Non Current Assets Annual | 713.19 | 655.00 | 557.86 | 204.84 | 145.59 | |
| Total Current Assets Annual | 567.98 | 470.67 | 368.07 | 339.51 | 322.70 | |
| Total Assets Annual | 1281.17 | 1125.67 | 925.93 | 544.36 | 468.29 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 125.56 | 178.26 | 5.13 | 21.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 73.92 | 113.66 | 33.12 | 52.09 | 55.75 | |
| Cash from Investing Activity Annual | -69.55 | -160.59 | -318.12 | -37.00 | -187.25 | |
| Cash from Financing Annual Activity | -22.09 | 61.21 | 296.91 | -29.45 | 154.97 | |
| Net Cash Flow Annual | - | 14.28 | 11.91 | -14.36 | 23.47 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 173.83 | 155.69 | 142.50 | 77.88 | 55.85 | |
| ROE Annual % | 10.37 | 8.31 | 10.13 | 19.55 | 23.11 | |
| ROCE Annual % | 14.41 | 11.19 | 13.90 | 26.88 | 28.71 | |
| Total Debt to Total Equity Annual | 0.06 | 0.08 | 0.00 | 0.00 | 0.22 | |
| EBDIT Annual Margin % | 13.96 | 12.94 | 12.62 | 18.98 | 18.10 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 473.11 | 467.27 | 484.83 | 412.80 | 409.27 | 390.38 | 426.26 | 435.45 | 440.90 | 434.77 | 388.48 | |
| Operating Expenses Qtr | 409.12 | 400.10 | 419.90 | 352.86 | 351.88 | 335.11 | 368.89 | 376.98 | 386.62 | 381.67 | 340.61 | |
| Operating Profit Qtr | 63.59 | 63.67 | 63.57 | 57.75 | 54.58 | 54.16 | 56.55 | 57.73 | 52.31 | 46.74 | 43.90 | |
| EBIDT Qtr Cr | 63.98 | 67.17 | 64.93 | 59.94 | 57.39 | 55.28 | 57.37 | 58.48 | 54.28 | 53.10 | 47.87 | |
| Depreciation Qtr | 16.07 | 15.09 | 15.11 | 14.11 | 16.02 | 15.96 | 15.63 | 15.32 | 16.54 | 17.82 | 10.19 | |
| Net Profit Qtr | 34.13 | 34.39 | 32.95 | 29.22 | 28.98 | 25.68 | 23.92 | 28.68 | 24.08 | 22.54 | 26.23 | |
| Basic EPS Qtr | 6.18 | 6.23 | 5.97 | 5.30 | 5.25 | 4.66 | 4.34 | 5.21 | 4.37 | 4.09 | 4.77 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1838.00 | 1661.37 | 1494.97 | 718.53 | 603.82 | |
| Operating Expenses Annual Cr | 1580.80 | 1432.86 | 1299.53 | 586.29 | 495.35 | |
| Operating Profit Annual | 249.76 | 223.02 | 183.44 | 123.06 | 104.74 | |
| Operating Profit Margin Annual % | 13.59 | 13.42 | 12.27 | 17.13 | 17.35 | |
| Total Expenses Annual Cr | 1660.56 | 1518.10 | 1360.24 | 612.11 | 515.76 | |
| EBIDT Annual Cr | 257.20 | 228.51 | 195.44 | 132.25 | 108.47 | |
| EBIDT Annual margin % | 13.99 | 13.75 | 13.07 | 18.41 | 17.96 | |
| Depreciation | 60.39 | 62.93 | 48.05 | 22.83 | 16.85 | |
| PAT Before ExtraOrdinary Items Annual Cr | 130.51 | 106.30 | 96.15 | 79.64 | 65.47 | |
| Net Profit Annual | 130.69 | 107.26 | 97.67 | 80.22 | 65.25 | |
| Basic EPS Annual | 23.62 | 19.38 | 17.70 | 15.47 | 13.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1047.73 | 915.17 | 805.16 | 408.77 | 286.19 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 99.69 | 105.54 | 156.89 | 2.39 | 36.13 | |
| Total Current Liabilities Annual Cr | 424.74 | 346.86 | 294.66 | 150.19 | 148.71 | |
| Total Capital Plus Liabilities Annual Cr | 1572.15 | 1367.57 | 1256.72 | 561.35 | 471.51 | |
| Fixed Assets Annual | 506.05 | 480.98 | 518.62 | 178.95 | 115.29 | |
| Total Non Current Assets Annual | 727.37 | 646.41 | 647.43 | 206.63 | 145.19 | |
| Total Current Assets Annual | 844.78 | 721.16 | 609.29 | 354.72 | 326.32 | |
| Total Assets Annual | 1572.15 | 1367.57 | 1256.72 | 561.35 | 471.51 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 19.96 | 2.61 | 5.13 | 21.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 43.26 | 152.39 | 29.36 | 47.77 | 56.83 | |
| Cash from Investing Activity Annual | -103.21 | -180.89 | -298.88 | -37.18 | -190.30 | |
| Cash from Financing Annual Activity | 16.18 | 60.85 | 291.79 | -24.59 | 156.94 | |
| Net Cash Flow Annual | - | 32.35 | 22.27 | -14.00 | 23.47 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 189.65 | 165.93 | 146.25 | 78.72 | 56.39 | |
| ROE Annual % | 12.47 | 11.71 | 12.13 | 19.62 | 22.80 | |
| ROCE Annual % | 17.15 | 16.22 | 15.31 | 26.61 | 28.38 | |
| Total Debt to Total Equity Annual | 0.10 | 0.08 | 0.01 | 0.00 | 0.21 | |
| EBDIT Annual Margin % | 14.05 | 13.79 | 13.17 | 18.64 | 18.07 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sbi Small Cap Fund | 5.72 | 74195820 | - | - |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | 1.93 | 74195822 | - | - |
| Icici Lombard General Insurance Company Ltd | 1.32 | 74195826 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Edward Menezes | 29.18 | 74195808 | 0 | 0 |
| Sunil Srinivasan Chari | 29.12 | 74195809 | 0 | 0 |
| Anita Menezes | 1.81 | 74195810 | 0 | 0 |
| Jyotishna Sunil Chari | 1.81 | 74195811 | 0 | 0 |
| Rossari Biotech India Pvt Ltd | 5.46 | 74195815 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Sbi Small Cap Fund | 5.72 | 74195820 |
| Uti Flexi Cap Fund | 4.57 | 74195821 |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | 1.93 | 74195822 |
| Motilal Oswal Small Cap Fund | 1.06 | 74195823 |
| Uti India Dynamic Equity Fund | 1.16 | 74195830 |
| Life Insurance Corporation Of India | 3.07 | 74195825 |
| Icici Lombard General Insurance Company Ltd | 1.32 | 74195826 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| May 24, 2023 | 0.5 | FINAL | - | Equity Share |
| Jul 07, 2022 | 0.5 | FINAL | - | Equity Share |
| Sep 08, 2021 | 0.5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Apr 29, 2024 | Audited Results & Final Dividend | - |
| Jan 20, 2024 | Quarterly Results | - |
| Oct 21, 2023 | Quarterly Results | - |
| Jul 29, 2023 | Quarterly Results | - |
| Apr 29, 2023 | Audited Results & Final Dividend | - |
| Feb 04, 2023 | Quarterly Results | - |
| Nov 05, 2022 | Quarterly Results | - |
| Aug 06, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results & Final Dividend | - |
| Feb 14, 2022 | Quarterly Results | - |
| Oct 30, 2021 | Quarterly Results | - |
| Jul 30, 2021 | Quarterly Results | - |
| May 14, 2021 | Audited Results & Final Dividend | - |
| Jan 23, 2021 | Quarterly Results | - |
| Oct 24, 2020 | Quarterly Results | - |
| Aug 21, 2020 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jul 2024
Rossari Biotech Ltd - 543213 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024.
26 Jun 2024
Rossari Biotech Ltd - 543213 - Closure of Trading Window
Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
11 Jun 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/Institutional Investor Meet/Con. Call/Updates.
31 May 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Incorporation of Rossari Global DMCC, a wholly owned subsidiary of the Company
27 May 2024
Rossari Biotech Ltd - 543213 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year 2023-24
22 May 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/Institutional Investor Meet/Con. Call/Updates.
15 May 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Demise
Intimation of demise of Ms. Usha Chari, Member of Promoter Group of the Company on May 15, 2024.
07 May 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Transcript of Q4 FY 24 for the Earnings Conference Call held on April 30, 2024
02 May 2024
Rossari Biotech Q4 Results Review - HPPC Pie Is Now More Broad-Based: Nirmal Bang
Expansion projects with peak revenue potential of Rs 4 billion
30 Apr 2024
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings Conference call for Q4 FY 24
